Hangzhou Huadi Group Co.,Ltd
|Main Market:||South America|
|No. of Employees:||200~300 People|
|Annual Sales:||US$ 15 Million - US$ 20 Million|
|Export p.c:||70% - 80%|
Introduction of Hangzhou Huadi Group Co.,ltd
Hangzhou Huadi Group Co.,Ltd is organized in 2015 based on the core subsidiary Hangzhou Huajin
Pharmaceutical Co., Ltd and four subsidiaries including Zhejiang Huajin Yike Pharmaceutical Co., Ltd ,
Zhejiang Huaercheng Bio-pharmaceutical Co., Ltd, Hangzhou Huajin Yunshang Pharmaceutical Co.,Ltd
and Hangzhou Mixi Bio-technology Co., Ltd.
Hangzhou Huajin Pharmaceutical was established in 1995 . Based on 20 years development with main
advantage on animaltissue extraction and peptides synthesis , we now become a large-scale health
industry group with business covering human medicine , food supplement , veterinary , pharmaceutical
ingredient , nutraceutical ingredient and cosmetic ingredient .
The group registered capital is RMB 100million , total floor area is over 600,000 m2 . The capsule products
plants , injection products plants and API plants belong to our subsidiaries are certificated with GMP . Our
animal-extracts and peptides occupy a big share of domestic market . And we also enjoy global reputation
from our customers around world because of our high quality products dedicated service , particularly like
South Korea , Germany , India , Mexico , Vietnam , etc.
Hangzhou Huadi Group is committed on human health. It is our unshirkable responsibility to improve people’s health with the best efforts on our products and services. We appreciate sincere partners over the world to work together on this lofty cause .